C

Citius Oncology Inc
NASDAQ:CTOR

Watchlist Manager
Citius Oncology Inc
NASDAQ:CTOR
Watchlist
Price: 1.145 USD -9.84% Market Closed
Market Cap: 95.6m USD

Operating Margin
Citius Oncology Inc

0%
Current
0%
Average
-4.2%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
0%
=
Operating Profit
-38.8m
/
Revenue
0

Operating Margin Across Competitors

No Stocks Found

Citius Oncology Inc
Glance View

Market Cap
95.6m USD
Industry
Biotechnology

Citius Oncology, Inc. is a pharmaceutical company, which engages in developing and commercializing targeted oncology therapies. The company is headquartered in New York City, New York. The company went IPO on 2022-10-14. The firm is focused on developing and commercializing targeted oncology therapies. The Company’s lead product candidate is LYMPHIR, an engineered IL-2 diphtheria toxin fusion protein, for the treatment of patients with persistent or recurrent CTCL, a rare form of non-Hodgkin lymphoma. LYMPHIR is a targeted immune therapy for relapsed or refractory cutaneous T-cell lymphoma (CTCL) indicated for use in Stage I-III disease after at least one prior systemic therapy. The company is a recombinant fusion protein that combines the IL-2 receptor binding domain with diphtheria toxin fragments. The agent specifically binds to IL-2 receptors on the cell surface, causing diphtheria toxin fragments that have entered cells to inhibit protein synthesis. After uptake into the cell, the diphtheria toxin (DT) fragment is cleaved and the free DT fragments inhibit protein synthesis, resulting in cell death.

CTOR Intrinsic Value
Not Available
C
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
0%
=
Operating Profit
-38.8m
/
Revenue
0
What is the Operating Margin of Citius Oncology Inc?

Based on Citius Oncology Inc's most recent financial statements, the company has Operating Margin of 0%.

Back to Top